{
  "DOI": "10.1038/ejhg.2010.175",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2010.175",
  "alternative-id": [
    "BFejhg2010175"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Maher",
      "given": "Eamonn R",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Neumann",
      "given": "Hartmut PH",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Richard",
      "given": "Stéphane",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        3,
        9
      ]
    ],
    "date-time": "2011-03-09T12:25:58Z",
    "timestamp": 1299673558000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:00:14Z",
    "timestamp": 1684429214000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        5,
        1
      ]
    ],
    "date-time": "2024-05-01T07:35:36Z",
    "timestamp": 1714548936639
  },
  "is-referenced-by-count": 509,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2011,
        3,
        9
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2011,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            3,
            9
          ]
        ],
        "date-time": "2011-03-09T00:00:00Z",
        "timestamp": 1299628800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2010175.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2010175",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2010175.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "617-623",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2011,
        3,
        9
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        3,
        9
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1093/qjmed/77.2.1151",
      "author": "ER Maher",
      "doi-asserted-by": "publisher",
      "first-page": "1151",
      "journal-title": "Quart J Med",
      "key": "BFejhg2010175_CR1",
      "unstructured": "Maher ER, Yates JRW, Harries R et al: Clinical-Features and Natural-History of von Hippel-Lindau Disease. Quart J Med 1990; 77: 1151–1163.",
      "volume": "77",
      "year": "1990"
    },
    {
      "DOI": "10.1016/S0140-6736(03)13643-4",
      "author": "RR Lonser",
      "doi-asserted-by": "publisher",
      "first-page": "2059",
      "journal-title": "Lancet",
      "key": "BFejhg2010175_CR2",
      "unstructured": "Lonser RR, Glenn GM, Walther M et al: Von-Hippel-Lindau disease. Lancet 2003; 361: 2059–2067.",
      "volume": "361",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0140-6736(04)15957-6",
      "author": "S Richard",
      "doi-asserted-by": "publisher",
      "first-page": "1231",
      "journal-title": "Lancet",
      "key": "BFejhg2010175_CR3",
      "unstructured": "Richard S, Lindau J, Graff J et al: Von Hippel-Lindau disease. Lancet 2004; 363: 1231–1234.",
      "volume": "363",
      "year": "2004"
    },
    {
      "DOI": "10.1006/geno.2000.6144",
      "author": "ER Woodward",
      "doi-asserted-by": "publisher",
      "first-page": "253",
      "journal-title": "Genomics",
      "key": "BFejhg2010175_CR4",
      "unstructured": "Woodward ER, Buchberger A, Clifford SC et al: Comparative sequence analysis of the VHL tumor suppressor gene. Genomics 2000; 65: 253–265.",
      "volume": "65",
      "year": "2000"
    },
    {
      "DOI": "10.1093/hmg/4.11.2139",
      "author": "FM Richards",
      "doi-asserted-by": "publisher",
      "first-page": "2139",
      "journal-title": "Hum Mol Gen",
      "key": "BFejhg2010175_CR5",
      "unstructured": "Richards FM, Payne SJ, Zbar B et al: Molecular Analysis of De-Novo Germline Mutations in the von Hippel-Lindau Disease Gene. Hum Mol Gen 1995; 4: 2139–2143.",
      "volume": "4",
      "year": "1995"
    },
    {
      "DOI": "10.1126/science.8493574",
      "author": "F Latif",
      "doi-asserted-by": "publisher",
      "first-page": "1317",
      "journal-title": "Science",
      "key": "BFejhg2010175_CR6",
      "unstructured": "Latif F, Tory K, Gnarra J et al: Identification of the von Hippel-Lindau disease tumor-suppressor gene. Science 1993; 260: 1317–1320.",
      "volume": "260",
      "year": "1993"
    },
    {
      "DOI": "10.1093/hmg/6.7.1051",
      "author": "ER Woodward",
      "doi-asserted-by": "publisher",
      "first-page": "1051",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2010175_CR7",
      "unstructured": "Woodward ER, Eng C, McMahon R et al: Genetic predisposition to phaeochromocytoma: Analysis of candidate genes GDNF, RET and VHL. Hum Mol Genet 1997; 6: 1051–1056.",
      "volume": "6",
      "year": "1997"
    },
    {
      "DOI": "10.1056/NEJMoa020152",
      "author": "HP Neumann",
      "doi-asserted-by": "publisher",
      "first-page": "1459",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2010175_CR8",
      "unstructured": "Neumann HP, Bausch B, McWhinney SR et al: Germ-line mutations in nonsyndromic Phaeochromocytoma. N Engl J Med 2002; 346: 1459–6621.",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1038/ng1019",
      "author": "SO Ang",
      "doi-asserted-by": "publisher",
      "first-page": "614",
      "journal-title": "Nat Genet",
      "key": "BFejhg2010175_CR9",
      "unstructured": "Ang SO, Chen H, Hirota K et al: Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 2002; 32: 614–621.",
      "volume": "32",
      "year": "2002"
    },
    {
      "DOI": "10.1182/blood-2003-07-2535",
      "author": "VR Gordeuk",
      "doi-asserted-by": "publisher",
      "first-page": "3924",
      "journal-title": "Blood",
      "key": "BFejhg2010175_CR10",
      "unstructured": "Gordeuk VR, Sergueeva AI, Miasnikova GY et al: Congenital disorder of oxygen-sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 2004; 103: 3924–3932.",
      "volume": "103",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.28.7.443",
      "author": "ER Maher",
      "doi-asserted-by": "publisher",
      "first-page": "443",
      "journal-title": "J Med Genet",
      "key": "BFejhg2010175_CR11",
      "unstructured": "Maher ER, Iselius L, Yates JR et al: Von Hippel-Lindau disease: A genetic study. J Med Genet 1991; 28: 443–447.",
      "volume": "28",
      "year": "1991"
    },
    {
      "DOI": "10.1016/0140-6736(91)90401-A",
      "author": "HP Neumann",
      "doi-asserted-by": "publisher",
      "first-page": "258",
      "journal-title": "Lancet",
      "key": "BFejhg2010175_CR12",
      "unstructured": "Neumann HP, Wiestler OD : Clustering of features and genetics of von Hippel-Lindau syndrome. Lancet 1991; 338: 258.",
      "volume": "338",
      "year": "1991"
    },
    {
      "DOI": "10.1016/S0022-5347(01)62509-6",
      "author": "HP Neumann",
      "doi-asserted-by": "publisher",
      "first-page": "1248",
      "journal-title": "J Urol.",
      "key": "BFejhg2010175_CR13",
      "unstructured": "Neumann HP, Bender BU, Berger DP et al: Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol. 1998; 160: 1248–1254.",
      "volume": "160",
      "year": "1998"
    },
    {
      "DOI": "10.1136/jmg.27.5.311",
      "author": "ER Maher",
      "doi-asserted-by": "publisher",
      "first-page": "311",
      "journal-title": "J Med Genet",
      "key": "BFejhg2010175_CR14",
      "unstructured": "Maher ER, Yates JRW, Ferguson-Smith MA : Statistical-Analysis of the 2 Stage Mutation Model in von Hippel- Lindau Disease and in Sporadic Cerebellar Haemangioblastoma and Renal-Cell Carcinoma. J Med Genet 1990b; 27: 311–314.",
      "volume": "27",
      "year": "1990"
    },
    {
      "DOI": "10.1007/s101430050024",
      "author": "S Richard",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Neurosurg Rev.",
      "key": "BFejhg2010175_CR15",
      "unstructured": "Richard S, David P, Marsot-Dupuch K et al: Central nervous system haemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurg Rev. 2000; 23: 1–22, discussion 23-4.",
      "volume": "23",
      "year": "2000"
    },
    {
      "DOI": "10.3171/jns.2003.98.1.0082",
      "author": "JE Wanebo",
      "doi-asserted-by": "publisher",
      "first-page": "82",
      "journal-title": "J Neurosurg",
      "key": "BFejhg2010175_CR16",
      "unstructured": "Wanebo JE, Lonser RR, Glenn GM et al: The natural history of central nervous system haemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2003; 98: 82–94.",
      "volume": "98",
      "year": "2003"
    },
    {
      "DOI": "10.1371/journal.pmed.0040060",
      "author": "DM Park",
      "doi-asserted-by": "publisher",
      "first-page": "e60",
      "journal-title": "PLoS Med.",
      "key": "BFejhg2010175_CR17",
      "unstructured": "Park DM, Zhuang Z, Chen L et al: von Hippel-Lindau disease-associated haemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007; 4: e60.",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.3171/jns.2003.98.1.0106",
      "author": "RR Lonser",
      "doi-asserted-by": "publisher",
      "first-page": "106",
      "journal-title": "J Neurosurg",
      "key": "BFejhg2010175_CR18",
      "unstructured": "Lonser RR, Weil RJ, Wanebo JE et al: Surgical management of spinal cord haemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2003; 98: 106–116.",
      "volume": "98",
      "year": "2003"
    },
    {
      "DOI": "10.3171/jns.2003.98.1.0095",
      "author": "RJ Weil",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "journal-title": "J Neurosurg.",
      "key": "BFejhg2010175_CR19",
      "unstructured": "Weil RJ, Lonser RR, DeVroom HL et al: Surgical management of brainstem haemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2003; 98: 95–105.",
      "volume": "98",
      "year": "2003"
    },
    {
      "author": "H Dollfus",
      "first-page": "3067",
      "journal-title": "Invest Ophthalmol Vis Sci",
      "key": "BFejhg2010175_CR20",
      "unstructured": "Dollfus H, Massin P, Taupin P et al: Ocular manifestations in von Hippel-Lindau disease: a clinical and molecular study. Invest Ophthalmol Vis Sci 2002; 43: 3067–3074.",
      "volume": "43",
      "year": "2002"
    },
    {
      "DOI": "10.1001/archopht.117.3.371",
      "author": "AR Webster",
      "doi-asserted-by": "publisher",
      "first-page": "371",
      "journal-title": "Archives of Ophthalmol",
      "key": "BFejhg2010175_CR21",
      "unstructured": "Webster AR, Maher ER, Moore AT : Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Archives of Ophthalmol 1999; 117: 371–378.",
      "volume": "117",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0161-6420(02)01159-4",
      "author": "LP Aiello",
      "doi-asserted-by": "publisher",
      "first-page": "1745",
      "journal-title": "Ophthalmol",
      "key": "BFejhg2010175_CR22",
      "unstructured": "Aiello LP, George DJ, Cahill MT et al: Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor SU5416. Ophthalmol 2002; 109: 1745–1751.",
      "volume": "109",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0002-9394(03)00101-6",
      "author": "JF Girmens",
      "doi-asserted-by": "publisher",
      "first-page": "194",
      "journal-title": "Am J Ophthalmol",
      "key": "BFejhg2010175_CR23",
      "unstructured": "Girmens JF, Erginay A, Massin P et al: Treatment of von Hippel-Lindau retinal haemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for haemangioblastomas. Am J Ophthalmol 2003; 136: 194–196.",
      "volume": "136",
      "year": "2003"
    },
    {
      "DOI": "10.1002/humu.20385",
      "author": "KR Ong",
      "doi-asserted-by": "publisher",
      "first-page": "143",
      "journal-title": "Hum Mut",
      "key": "BFejhg2010175_CR24",
      "unstructured": "Ong KR, Woodward ER, Killick P et al: Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mut 2007; 28: 143–149.",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1097/01.ju.0000092780.85876.de",
      "author": "M Roupret",
      "doi-asserted-by": "publisher",
      "first-page": "1752",
      "journal-title": "J Urol",
      "key": "BFejhg2010175_CR25",
      "unstructured": "Roupret M, Hopirtean V, Mejean A et al: Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: A single center experience. J Urol 2003; 170: 1752–1755.",
      "volume": "170",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0022-5347(17)37636-X",
      "author": "LL Keeler",
      "doi-asserted-by": "publisher",
      "first-page": "1588",
      "journal-title": "J Urol",
      "key": "BFejhg2010175_CR26",
      "unstructured": "Keeler LL, Klauber GT : Von Hippel-Lindau disease and renal cell carcinoma in a 16-year-old boy. J Urol 1992; 147: 1588–1591.",
      "volume": "147",
      "year": "1992"
    },
    {
      "DOI": "10.1016/S1535-6108(02)00071-5",
      "author": "SJ Mandriota",
      "doi-asserted-by": "publisher",
      "first-page": "459",
      "journal-title": "Cancer Cell",
      "key": "BFejhg2010175_CR27",
      "unstructured": "Mandriota SJ, Turner KJ, Davies DR et al: HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 2002; 1: 459–468.",
      "volume": "1",
      "year": "2002"
    },
    {
      "DOI": "10.2214/ajr.159.6.1442389",
      "author": "PL Choyke",
      "doi-asserted-by": "publisher",
      "first-page": "1229",
      "journal-title": "American J Roentgenology",
      "key": "BFejhg2010175_CR28",
      "unstructured": "Choyke PL, Glenn GM, Walther MM et al: The natural history of renal lesions in Von Hippel-Lindau disease: a serial CT study in 28 patients. American J Roentgenology 1992; 159: 1229–1234.",
      "volume": "159",
      "year": "1992"
    },
    {
      "DOI": "10.1016/S0022-5347(05)68930-6",
      "author": "MM Walther",
      "doi-asserted-by": "publisher",
      "first-page": "1475",
      "journal-title": "J Urol",
      "key": "BFejhg2010175_CR29",
      "unstructured": "Walther MM, Choyke PL, Glenn G et al: Renal cancer in families with hereditary renal cancer: Prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 1999; 161: 1475–1479.",
      "volume": "161",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0022-5347(01)67318-X",
      "author": "F Steinbach",
      "doi-asserted-by": "publisher",
      "first-page": "1812",
      "journal-title": "J Urol",
      "key": "BFejhg2010175_CR30",
      "unstructured": "Steinbach F, Novick AC, Zincke H et al: Treatment of Renal-Cell Carcinoma in von Hippel-Lindau Disease - a Multicenter Study. J Urol 1995; 153: 1812–1816.",
      "volume": "153",
      "year": "1995"
    },
    {
      "DOI": "10.1097/00007890-199712270-00017",
      "author": "DA Goldfarb",
      "doi-asserted-by": "publisher",
      "first-page": "1726",
      "journal-title": "Transplantation",
      "key": "BFejhg2010175_CR31",
      "unstructured": "Goldfarb DA, Neumann HPH, Penn I et al: Results of renal transplantation in patients with renal cell carcinoma in Von Hippel-Lindau disease. Transplantation 1998; 64: 1726–1729.",
      "volume": "64",
      "year": "1998"
    },
    {
      "DOI": "10.1053/gast.2000.18143",
      "author": "PR Hammel",
      "doi-asserted-by": "publisher",
      "first-page": "1087",
      "journal-title": "Gastroenterology",
      "key": "BFejhg2010175_CR32",
      "unstructured": "Hammel PR, Vilgrain V, Terris B et al: Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d′Etude de la Maladie de von Hippel-Lindau. Gastroenterology 2000; 119: 1087–1095.",
      "volume": "119",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.surg.2007.09.012",
      "author": "JA Blansfield",
      "doi-asserted-by": "publisher",
      "first-page": "814",
      "journal-title": "Surgery",
      "key": "BFejhg2010175_CR33",
      "unstructured": "Blansfield JA, Choyke L, Morita SY et al: Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery 2007; 142: 814–818.",
      "volume": "142",
      "year": "2007"
    },
    {
      "DOI": "10.1097/MPA.0b013e31815f394a",
      "author": "O Corcos",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Pancreas",
      "key": "BFejhg2010175_CR34",
      "unstructured": "Corcos O, Couvelard A, Giraud S et al: Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features. Pancreas 2008; 37: 85–93.",
      "volume": "37",
      "year": "2008"
    },
    {
      "DOI": "10.1677/ERC-10-0037",
      "author": "Z Erlic",
      "doi-asserted-by": "publisher",
      "first-page": "875",
      "journal-title": "Endocr Relat Cancer",
      "key": "BFejhg2010175_CR35",
      "unstructured": "Erlic Z, Ploeckinger U, Cascón A et al: Systematic comparison of sporadic and syndromic pancreatic islet cell tumors. Endocr Relat Cancer 2010; 17: 875–883. Print 2010.",
      "volume": "17",
      "year": "2010"
    },
    {
      "DOI": "10.1001/jama.1997.03540420057030",
      "author": "TJ Manski",
      "doi-asserted-by": "publisher",
      "first-page": "1461",
      "journal-title": "Jama-Journal of the American Medical Association",
      "key": "BFejhg2010175_CR36",
      "unstructured": "Manski TJ, Heffner DK, Glenn GM et al: Endolymphatic sac tumors—A source of morbid hearing loss in von Hippel-Lindau disease. Jama-Journal of the American Medical Association 1997; 277: 1461–1466.",
      "volume": "277",
      "year": "1997"
    },
    {
      "DOI": "10.1210/jc.2009-0354",
      "author": "CC Boedeker",
      "doi-asserted-by": "publisher",
      "first-page": "1938",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "BFejhg2010175_CR37",
      "unstructured": "Boedeker CC, Erlic Z, Richard S et al: Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 2009; 94: 1938–1944.",
      "volume": "94",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0090-4295(97)00074-5",
      "author": "PL Choyke",
      "doi-asserted-by": "publisher",
      "first-page": "926",
      "journal-title": "Urology",
      "key": "BFejhg2010175_CR38",
      "unstructured": "Choyke PL, Glenn GM, Wagner JP et al: Epididymal cystadenomas in von Hippel-Lindau disease. Urology 1997; 49: 926–931.",
      "volume": "49",
      "year": "1997"
    },
    {
      "DOI": "10.1007/s00404-010-1386-4",
      "author": "DB Zanotelli",
      "doi-asserted-by": "publisher",
      "first-page": "343",
      "journal-title": "Arch Gynecol Obstet",
      "key": "BFejhg2010175_CR39",
      "unstructured": "Zanotelli DB, Bruder E, Wight E et al: Bilateral papillary cystadenoma of the mesosalpinx: a rare manifestation of Von Hippel-Lindau disease. Arch Gynecol Obstet 2010; 282: 343–346.",
      "volume": "282",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.95.20.11661",
      "author": "O Iliopoulos",
      "doi-asserted-by": "publisher",
      "first-page": "11661",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2010175_CR40",
      "unstructured": "Iliopoulos O, Ohh M, Kaelin Jr WG : pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc Natl Acad Sci USA 1998; 95: 11661–1166.",
      "volume": "95",
      "year": "1998"
    },
    {
      "DOI": "10.1093/hmg/5.5.639",
      "author": "FM Richards",
      "doi-asserted-by": "publisher",
      "first-page": "639",
      "journal-title": "Hum Mol Gen",
      "key": "BFejhg2010175_CR41",
      "unstructured": "Richards FM, Schofield PN, Fleming S : Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. Hum Mol Gen 1996; 5: 639–644.",
      "volume": "5",
      "year": "1996"
    },
    {
      "DOI": "10.1016/S0046-8177(97)90035-6",
      "author": "CL Corless",
      "doi-asserted-by": "publisher",
      "first-page": "459",
      "journal-title": "Hum Path",
      "key": "BFejhg2010175_CR42",
      "unstructured": "Corless CL, Kibel AS, Iliopoulos O et al: Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues. Hum Path 1997; 28: 459–464.",
      "volume": "28",
      "year": "1997"
    },
    {
      "DOI": "10.1093/hmg/3.8.1303",
      "author": "PA Crossey",
      "doi-asserted-by": "publisher",
      "first-page": "1303",
      "journal-title": "Hum Mol Gen",
      "key": "BFejhg2010175_CR43",
      "unstructured": "Crossey PA, Richards FM, Foster K et al: Identification of intragenic mutations in the von Hippel-Lindau disease tumor-suppressor gene and correlation with disease phenotype. Hum Mol Gen 1994; 3: 1303–1308.",
      "volume": "3",
      "year": "1994"
    },
    {
      "author": "M Nordstrom-O′Brien",
      "first-page": "521",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2010175_CR44",
      "unstructured": "Nordstrom-O′Brien M, van der Luijt RB, van Rooijen E et al: Genetic analysis of von Hippel-Lindau disease. Hum Mutat 2010; 31: 521–537.",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1002/humu.20948",
      "author": "G Franke",
      "doi-asserted-by": "publisher",
      "first-page": "776",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2010175_CR45",
      "unstructured": "Franke G, Bausch B, Hoffmann MM et al: Alu-Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype-phenotype correlations in VHL patients. Hum Mutat 2009; 30: 776–786.",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1002/humu.10302",
      "author": "JK Maranchie",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2010175_CR46",
      "unstructured": "Maranchie JK, Afonso A, Albert PS et al: Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Hum Mutat 2004; 23: 40–46.",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1002/humu.20496",
      "author": "A Cascón",
      "doi-asserted-by": "publisher",
      "first-page": "613",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2010175_CR47",
      "unstructured": "Cascón A, Escobar B, Montero-Conde C et al: Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients. Hum Mutat 2007; 28: 613–621.",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1002/humu.1380050109",
      "author": "F Chen",
      "doi-asserted-by": "publisher",
      "first-page": "66",
      "journal-title": "Hum Mut",
      "key": "BFejhg2010175_CR48",
      "unstructured": "Chen F, Kishida T, Yao M et al: Germline Mutations in the von Hippel-Lindau Disease Tumor-Suppressor Gene—Correlations with Phenotype. Hum Mut 1995; 5: 66–75.",
      "volume": "5",
      "year": "1995"
    },
    {
      "DOI": "10.1136/jmg.33.4.328",
      "author": "ER Maher",
      "doi-asserted-by": "publisher",
      "first-page": "328",
      "journal-title": "J Med Genet",
      "key": "BFejhg2010175_CR49",
      "unstructured": "Maher ER, Webster AR, Richards FM et al: Phenotypic expression in von Hippel-Lindau disease: Correlations with germline VHL gene mutations. J Med Genet 1996; 33: 328–332.",
      "volume": "33",
      "year": "1996"
    },
    {
      "DOI": "10.1677/erc.1.00683",
      "author": "ER Woodward",
      "doi-asserted-by": "publisher",
      "first-page": "415",
      "journal-title": "Endocr Relat Cancer",
      "key": "BFejhg2010175_CR50",
      "unstructured": "Woodward ER, Maher ER : Von Hippel-Lindau disease and endocrine tumour susceptibility. Endocr Relat Cancer 2006; 13: 415–425.",
      "volume": "13",
      "year": "2006"
    },
    {
      "DOI": "10.1007/BF00223868",
      "author": "H Brauch",
      "doi-asserted-by": "publisher",
      "first-page": "551",
      "journal-title": "Hum Genet",
      "key": "BFejhg2010175_CR51",
      "unstructured": "Brauch H, Kishida T, Glavac D et al: Von Hippel-Lindau (VHL) Disease with phaeochromocytoma in the Black- Forest region of Germany - Evidence for a founder Effect. Hum Genet 1995; 95: 551–556.",
      "volume": "95",
      "year": "1995"
    },
    {
      "DOI": "10.1093/hmg/3.12.2169",
      "author": "K Foster",
      "doi-asserted-by": "publisher",
      "first-page": "2169",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2010175_CR52",
      "unstructured": "Foster K, Prowse A, van den Berg A et al: Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 1994; 3: 2169–2173.",
      "volume": "3",
      "year": "1994"
    },
    {
      "DOI": "10.1038/ng0594-85",
      "author": "JR Gnarra",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Nat Genet",
      "key": "BFejhg2010175_CR53",
      "unstructured": "Gnarra JR, Tory K, Weng Y et al: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994; 7: 85–90.",
      "volume": "7",
      "year": "1994"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-3074",
      "author": "RE Banks",
      "doi-asserted-by": "publisher",
      "first-page": "2000",
      "journal-title": "Cancer Res",
      "key": "BFejhg2010175_CR54",
      "unstructured": "Banks RE, Tirukonda P, Taylor C et al: Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res 2006; 66: 2000–2011.",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1002/cncr.24232",
      "author": "WG Kaelin Jr",
      "doi-asserted-by": "publisher",
      "first-page": "2262",
      "journal-title": "Cancer",
      "key": "BFejhg2010175_CR55",
      "unstructured": "Kaelin Jr WG : Treatment of kidney cancer; insights provided by the VHL tumor-suppressor protein. Cancer 2009; 115: 2262–2272.",
      "volume": "115",
      "year": "2009"
    },
    {
      "DOI": "10.1038/20459",
      "author": "PH Maxwell",
      "doi-asserted-by": "publisher",
      "first-page": "271",
      "journal-title": "Nature",
      "key": "BFejhg2010175_CR56",
      "unstructured": "Maxwell PH, Wiesener MS, Chang GT-W et al: The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271–275.",
      "volume": "399",
      "year": "1999"
    },
    {
      "DOI": "10.1126/science.284.5414.657",
      "author": "T Kamura",
      "doi-asserted-by": "publisher",
      "first-page": "657",
      "journal-title": "Science",
      "key": "BFejhg2010175_CR57",
      "unstructured": "Kamura T, Koepp DM, Conrad MN et al: Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 1999; 284: 657–661.",
      "volume": "284",
      "year": "1999"
    },
    {
      "DOI": "10.1126/science.1059817",
      "author": "M Ivan",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "journal-title": "Science",
      "key": "BFejhg2010175_CR58",
      "unstructured": "Ivan M, Kondo K, Yang H et al: HIF-alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464–468.",
      "volume": "292",
      "year": "2001"
    },
    {
      "DOI": "10.1126/science.1059796",
      "author": "P Jaakkola",
      "doi-asserted-by": "publisher",
      "first-page": "468",
      "journal-title": "Science",
      "key": "BFejhg2010175_CR59",
      "unstructured": "Jaakkola P, Mole DR, Tian YM et al: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468–472.",
      "volume": "292",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S1535-6108(02)00043-0",
      "author": "K Kondo",
      "doi-asserted-by": "publisher",
      "first-page": "237",
      "journal-title": "Cancer Cell",
      "key": "BFejhg2010175_CR60",
      "unstructured": "Kondo K, Klco J, Nakamura E et al: Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 2002; 1: 237–246.",
      "volume": "1",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S1535-6108(02)00044-2",
      "author": "JK Maranchie",
      "doi-asserted-by": "publisher",
      "first-page": "247",
      "journal-title": "Cancer Cell",
      "key": "BFejhg2010175_CR61",
      "unstructured": "Maranchie JK, Vasselli JR, Riss J et al: The contribution of VHL substrate binding and HIF1 to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 2002; 1: 247–255.",
      "volume": "1",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.284.5413.455",
      "author": "CE Stebbins",
      "doi-asserted-by": "publisher",
      "first-page": "455",
      "journal-title": "Science",
      "key": "BFejhg2010175_CR62",
      "unstructured": "Stebbins CE, Kaelin WG, Pavletich NP : Structure of the VHL-ElonginC-ElonginB complex: Implications for VHL tumor suppressor function. Science 1999; 284: 455–461.",
      "volume": "284",
      "year": "1999"
    },
    {
      "DOI": "10.1093/hmg/10.10.1029",
      "author": "SC Clifford",
      "doi-asserted-by": "publisher",
      "first-page": "1029",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2010175_CR63",
      "unstructured": "Clifford SC, Cockman ME, Smallwood AC et al: Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 2001; 10: 1029–1038.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/10.10.1019",
      "author": "MA Hoffman",
      "doi-asserted-by": "publisher",
      "first-page": "1019",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2010175_CR64",
      "unstructured": "Hoffman MA, Ohh M, Yang H et al: von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to down regulate HIF. Hum Mol Genet 2001; 10: 1019–1027.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.ccr.2005.06.015",
      "author": "S Lee",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Cancer Cell",
      "key": "BFejhg2010175_CR65",
      "unstructured": "Lee S, Nakamura E, Yang H et al: Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial phaeochromocytoma genes: developmental culling and cancer. Cancer Cell 2005; 8: 155–167.",
      "volume": "8",
      "year": "2005"
    },
    {
      "DOI": "10.1182/blood-2003-07-2550",
      "author": "E Liu",
      "doi-asserted-by": "publisher",
      "first-page": "1937",
      "journal-title": "Blood",
      "key": "BFejhg2010175_CR66",
      "unstructured": "Liu E, Percy MJ, Amos CI et al: The worldwide distribution of the VHL 598C\u0026gt;T mutation indicates a single founding event. Blood 2004; 103: 1937–1940.",
      "volume": "103",
      "year": "2004"
    },
    {
      "DOI": "10.1086/302037",
      "author": "AR Webster",
      "doi-asserted-by": "publisher",
      "first-page": "1025",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2010175_CR67",
      "unstructured": "Webster AR, Richards FM, MacRonald FE et al: An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: Evidence for modifier effects. Am J Hum Genet 1998; 63: 1025–1035.",
      "volume": "63",
      "year": "1998"
    },
    {
      "author": "M Zatyka",
      "first-page": "3803",
      "journal-title": "Cancer Res",
      "key": "BFejhg2010175_CR68",
      "unstructured": "Zatyka M, da Silva NF, Clifford SC et al: Identification of cyclin D1 (CCND1) and other novel targets for the VHL tumour suppressor gene by expression array analysis and investigation of CCND1 genotype as a modifier in von Hippel-Lindau disease. Cancer Res 2002; 62: 3803–3811.",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1371/journal.pone.0006037",
      "author": "C Ricketts",
      "doi-asserted-by": "publisher",
      "first-page": "e6037",
      "journal-title": "PLoS One",
      "key": "BFejhg2010175_CR69",
      "unstructured": "Ricketts C, Zeegers MP, Lubinski J et al: Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma. PLoS One 2009; 4: e6037.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJM199906173402404",
      "author": "G Eisenhofer",
      "doi-asserted-by": "publisher",
      "first-page": "1872",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2010175_CR70",
      "unstructured": "Eisenhofer G, Lenders JW, Linehan WM et al: Plasma normetanephrine and metanephrine for detecting Phaeochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 1999; 340: 1872–1879.",
      "volume": "340",
      "year": "1999"
    },
    {
      "DOI": "10.1007/s00268-002-6632-x",
      "author": "MK Walz",
      "doi-asserted-by": "publisher",
      "first-page": "1005",
      "journal-title": "World J Surg",
      "key": "BFejhg2010175_CR71",
      "unstructured": "Walz MK, Peitgen K, Neumann HP et al: Endoscopic treatment of solitary, bilateral, multiple, and recurrent Phaeochromocytomas and paragangliomas. World J Surg 2002; 26: 1005–1012.",
      "volume": "26",
      "year": "2002"
    },
    {
      "author": "HP Neumann",
      "first-page": "2608",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "BFejhg2010175_CR72",
      "unstructured": "Neumann HP, Reincke M, Bender BU et al: Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary Phaeochromocytoma. J Clin Endocrinol Metab 1999; 84: 2608–2610.",
      "volume": "84",
      "year": "1999"
    },
    {
      "DOI": "10.1111/j.1399-0004.2010.01333.x",
      "author": "CR Lammens",
      "doi-asserted-by": "publisher",
      "first-page": "483",
      "journal-title": "Clin Genet",
      "key": "BFejhg2010175_CR73",
      "unstructured": "Lammens CR, Bleiker EM, Verhoef S et al: Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distress. Clin Genet 2010; 77: 483–491.",
      "volume": "77",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S0140-6736(09)60229-4",
      "author": "BI Rini",
      "doi-asserted-by": "publisher",
      "first-page": "1119",
      "journal-title": "Lancet",
      "key": "BFejhg2010175_CR74",
      "unstructured": "Rini BI, Campbell SC, Escudier B : Renal cell carcinoma. Lancet 2009; 373: 1119–1132.",
      "volume": "373",
      "year": "2009"
    },
    {
      "DOI": "10.1210/jc.2008-1972",
      "author": "C Jimenez",
      "doi-asserted-by": "publisher",
      "first-page": "386",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "BFejhg2010175_CR75",
      "unstructured": "Jimenez C, Cabanillas ME, Santarpia L et al: Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in Phaeochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab 2009; 94: 386–391.",
      "volume": "94",
      "year": "2009"
    },
    {
      "DOI": "10.2174/1566524043359827",
      "author": "ER Maher",
      "doi-asserted-by": "publisher",
      "first-page": "833",
      "journal-title": "Curr Mol Med",
      "key": "BFejhg2010175_CR76",
      "unstructured": "Maher ER : Von Hippel-Lindau disease. Curr Mol Med 2004; 4: 833–842.",
      "volume": "4",
      "year": "2004"
    }
  ],
  "reference-count": 76,
  "references-count": 76,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2010175"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "von Hippel–Lindau disease: A clinical and scientific review"
  ],
  "type": "journal-article",
  "volume": "19"
}